pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Preclinical
RDX-10531
Unspecified
$ARDXARDELYX, INC.
0 catalysts
Phase 2
REC-1245
Lymphoma
$RXRXRECURSION PHARMACEUTICALS, INC.
0 catalysts
Phase 1
REC-4539
Gastric Cancer
$RXRXRECURSION PHARMACEUTICALS, INC.
0 catalysts
Phase 2
← prev
page 126 of 231
next →
131
Pain89
Neurology1
REC-4881
Familial Adenomatous Polyposis
Dual specificity mitogen-activated protein kinase kinase 1Dual specificity mitogen-activated protein kinase kinase 2
$RXRXRECURSION PHARMACEUTICALS, INC.
0 catalysts
Preclinical
RECCE-529
Coronavirus Disease 2019 (COVID-19)
Recce Pharmaceuticals Ltd
0 catalysts
REGADENOSON
REGADENOSON (REGADENOSON)
APOTEX
0 catalysts
Phase 2
REGV-131
Hemophilia B (Factor IX Deficiency)
$REGNREGENERON PHARMACEUTICALS, INC.
0 catalysts
Phase 2
REM-422
Adenoid Cystic Carcinoma (ACC)
Remix Therapeutics Inc
0 catalysts
RENACIDIN
RENACIDIN (CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE)
UNITED GUARDIAN
0 catalysts
Preclinical
REP-0003
Homozygous Familial Hypercholesterolemia (HoFH)
Repair Biotechnologies Inc
0 catalysts
Phase 3
RESCAP
Acute Renal Failure (ARF) (Acute Kidney Injury)
Alloksys Life Sciences BV
0 catalysts
Preclinical
REV-0100
Juvenile Macular Degeneration (Stargardt Disease)
ReVision Therapeutics Inc
0 catalysts
Phase 2
REVTX-300
Chronic Kidney Disease (Chronic Renal Failure)
$REVBREVELATION BIOSCIENCES, INC.
0 catalysts
Phase 1
REX-8756
Asthma
Recludix Pharma Inc
0 catalysts
Preclinical
RFT-1041
Alzheimer's Disease
RAFT Pharmaceuticals LLC
0 catalysts
Preclinical
RFT-1124
Post-Operative Pain
RAFT Pharmaceuticals LLC
0 catalysts
Phase 2
RG-6351
Diabetic Macular Edema
Genentech Inc
0 catalysts
Phase 1
RG-6538
Refractory Multiple Myeloma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 1
RG-6540
Diffuse Large B-Cell Lymphoma
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6596
Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast…
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
RG-6794
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast…
Genentech Inc
0 catalysts
Phase 1
RGDCRAdcox-2F
Pancreatic Cancer
University of Minnesota
0 catalysts
Phase 2
RGI-2001
Graft Versus Host Disease (GVHD)
REGiMMUNE Ltd
0 catalysts
Preclinical
RGN-6024
Glioblastoma Multiforme (GBM)
Reglagene Holding Inc
0 catalysts
Phase 1
RGT-61159
Adenoid Cystic Carcinoma (ACC)
Rgenta Therapeutics Inc
0 catalysts
Phase 1
RGVax
Human Papillomavirus (HPV) Associated Cancer
Pathovax LLC
0 catalysts
Preclinical
RHLAM-111
Laminin-Deficient Congenital Muscular Dystrophy (LAMA2 MD or LAMA2-Related Mu…
Sarcomatrix Therapeutics Corp
0 catalysts
Phase 1
RIM-730
Coronavirus Disease 2019 (COVID-19)
RNAimmune Inc
0 catalysts
RINGERS
RINGERS (SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE,)
BAXTER HLTHCARE
0 catalysts
Phase 2
RIV3 + rC19
Coronavirus Disease 2019 (COVID-19)
$SNYSanofi
0 catalysts